Illumina is committed to upholding a proven track record of solutions that empower researchers to advance and accelerate their sequencing. That’s why we have invested billions into our research and development and infrastructure to ensure we can equip you with what you need to succeed.
When you partner with Illumina, you’ll get more than just leading-edge technology–you become part of a community with like-minded goals.
Our pursuit of innovation continues to inspire scientists to join our growing genomics community, and our proven performance has contributed to Illumina being cited more than any other sequencing company.
Trainings per year
Illumina Solution Centers
in R&D investment
Illumina provides a wide range of global, in-language support including remote technical support 24/5, onsite training, instrument qualification and customized onboarding solutions. Because of this, 9 out of 10 customers find it easy to do business with our team.
Become a part of a community advancing science together by leading the latest advancements in research and sharing best practices.
Illumina partnerships are expanding access to NGS, pioneering new applications and technologies, providing funding for innovative startups, and more.
Lessen time-to-insight with simple workflows from library prep to data analysis.
Reduce your environmental footprint with sustainable solutions.
NextSeq 1000 and NextSeq 2000 Sequencing Systems are flexible and scalable, empowering scientists to explore current and emerging applications like single cell, whole exome, and RNA sequencing. These easy-to-use systems feature an improved user experience with simplified run setup, minimal touchpoints, and flexible informatics solutions, including onboard DRAGEN. The breakthrough system design uses integrated reagent cartridges to minimize waste volume and improve recyclability.
With the help of the NextSeq 2000, Jun Xia, PhD and Yusi Fu, PhD of Creighton University developed highly accurate single-cell sequencing methods to detect cancer biomarkers. Hear how the NextSeq 2000 fast-tracked their research, opening doors with collaborators to better understand the fundamental processes that drive cancer.
Achieve the next level of scale, cost efficiencies, and sequencing capabilities on NextSeq 1000 and NextSeq 2000 Sequencing Systems. Coming in the first half of 2024, XLEAP-SBS Chemistry on existing kits (P1/P2/P3) and a new P4 flow cell will offer 1.7B reads and allow for 500Gb of genomic data.
"Using the NextSeq 2000 instrument has put our laboratory [into] a completely different league. The higher throughput and faster turnaround time made it possible for us to generate our results and reports much faster and [in] a more comprehensive way."
With the NextSeq 1000 and NextSeq 2000 onboard DRAGEN software, labs can reduce the need for additional computing infrastructure and bioinformatics resources. And with decreased data analysis complexity, researchers can efficiently find key insights in large data sets.
3x reduction in touchpoints for analysis data with BaseSpace
6x faster on-board secondary analysis than Local Run Manager
10+ pipelines that support a wide variety of experiment types
80% less energy for a more sustainable workplace
Up to 5x decrease in data footprint possible with ORA Compression
In this video, learn about the robustness of the NextSeq 2000 System and how it was able to support Dr Tomas Szemes’ team from Comenius University Science Park, in Slovakia, to double their previous sequencing efforts.
Hear from researchers who have used the NextSeq 1000 and NextSeq 2000 Systems for genomic surveillance, CRISPR screening, single-cell RNA Seq, and more, in this introductory video.
Gain a deeper perspective on the flexibility, streamlined workflow, flow cell configurations, informatics, and future innovations of the NextSeq 1000 and NextSeq 2000 Systems in this webinar.